This study is currently recruiting participants.
Verified by Penwest Pharmaceuticals Co., December 2009
First Received: December 17, 2009 Last Updated: December 18, 2009 History of Changes
| Sponsor: | Penwest Pharmaceuticals Co. | ||
|---|---|---|---|
| Information provided by: | Penwest Pharmaceuticals Co. | ||
| ClinicalTrials.gov Identifier: | NCT01035671 |
| Condition | Intervention | Phase |
|---|---|---|
| Friedreich's Ataxia | Drug: alpha-tocopherolquinone (A0001) Drug: placebo | Phase II |
